Statistics
Publications
2
Citations
96
H-Index
2
Active since
2020
Affiliations
Nurix (United States)(Current)
Timothy Ingallinera is an author at Nurix (United States) specializing in cancer immunotherapy, lymphoid neoplasms, and btk inhibitors.
Publications per year
2020–2021
2
2
Nx-2127, a Degrader of BTK and IMiD Neosubstrates, for the Treatment of B-Cell Malignancies
Daniel Robbins, Aileen Kelly, May Tan et al. · Blood · 2020 · 46 citations
1–2 of 2